Literature DB >> 19951107

Miltefosine treatment of Leishmania major infection: an observational study involving Dutch military personnel returning from northern Afghanistan.

P P A M van Thiel1, T Leenstra, P A Kager, H J de Vries, M van Vugt, W F van der Meide, A Bart, J E Zeegelaar, A van der Sluis, H D F H Schallig, T van Gool, W R Faber, P J de Vries.   

Abstract

In a retrospective, observational study involving 34 patients with Leishmania major infection, 31 of whom had experienced unsuccessful treatment with intralesional antimony (ilSb(v)), miltefosine proved effective. Thirty patients experienced cure after receipt of miltefosine, 3 after receipt of additional ilSb(v), and 1 after 28 daily intravenous injections of antimony. Temporary diminution of ejaculate volume was reported by 21 patients.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 19951107     DOI： 10.1086/648726

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  22 in total

Review 1.  Leishmaniasis in the United States: treatment in 2012.

Authors:  Henry W Murray
Journal:  Am J Trop Med Hyg       Date:  2012-03       Impact factor: 2.345

2.  Variation in clinical presentation and genotype of causative Leishmania major strain in cutaneous leishmaniasis in north and south Afghanistan.

Authors:  Pieter-Paul A M van Thiel; Tom van Gool; William R Faber; Tjalling Leenstra; Piet A Kager; Aldert Bart
Journal:  Am J Trop Med Hyg       Date:  2011-07       Impact factor: 2.345

3.  Cutaneous leishmaniasis in travellers: a focus on epidemiology and treatment in 2015.

Authors:  Adrienne J Showler; Andrea K Boggild
Journal:  Curr Infect Dis Rep       Date:  2015-07       Impact factor: 3.725

4.  [Cutaneous leishmaniasis. Diagnosis and therapy in northern Afghanistan].

Authors:  R Dieterle; H Pillekamp
Journal:  Hautarzt       Date:  2014-02       Impact factor: 0.751

5.  Case Report: Old World Mucosal Leishmaniasis: Report of Five Imported Cases to the Hospital for Tropical Diseases, London, United Kingdom.

Authors:  Trupti A Patel; Glenis K Scadding; David E Phillips; Diana N Lockwood
Journal:  Am J Trop Med Hyg       Date:  2017-10       Impact factor: 2.345

Review 6.  Antiparasitic therapy.

Authors:  Shanthi Kappagoda; Upinder Singh; Brian G Blackburn
Journal:  Mayo Clin Proc       Date:  2011-06       Impact factor: 7.616

7.  Cutaneous leishmaniasis (Leishmania major infection) in Dutch troops deployed in northern Afghanistan: epidemiology, clinical aspects, and treatment.

Authors:  Pieter-Paul van Thiel; Tjalling Leenstra; Henry J de Vries; Allard van der Sluis; Tom van Gool; Alex C Krull; Michèle van Vugt; Peter J de Vries; Jimmy E Zeegelaar; Aldert Bart; Wendy F van der Meide; Henk D F H Schallig; William R Faber; Piet A Kager
Journal:  Am J Trop Med Hyg       Date:  2010-12       Impact factor: 2.345

Review 8.  Leishmaniasis: new insights from an old and neglected disease.

Authors:  S Antinori; L Schifanella; M Corbellino
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-05-01       Impact factor: 3.267

9.  Noninferiority of miltefosine versus meglumine antimoniate for cutaneous leishmaniasis in children.

Authors:  Luisa Consuelo Rubiano; María Consuelo Miranda; Sandra Muvdi Arenas; Luz Mery Montero; Isabel Rodríguez-Barraquer; Daniel Garcerant; Martín Prager; Lyda Osorio; Maria Ximena Rojas; Mauricio Pérez; Ruben Santiago Nicholls; Nancy Gore Saravia
Journal:  J Infect Dis       Date:  2012-01-11       Impact factor: 5.226

10.  The antileishmanial activity of isoforms 6- and 8-selective histone deacetylase inhibitors.

Authors:  Quaovi Sodji; Vishal Patil; Surendra Jain; James R Kornacki; Milan Mrksich; Babu L Tekwani; Adegboyega K Oyelere
Journal:  Bioorg Med Chem Lett       Date:  2014-09-04       Impact factor: 2.823
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.